Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

New psoriasis treatments are effective but come with side effects and risks.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Skin reactions from cancer treatments might predict how well the treatments work.

Bortezomib chemotherapy can cause temporary skin rashes.

Phosphatidic acid may promote hair growth like minoxidil.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib may help treat hair loss in children with alopecia areata.

FA-MNPs effectively targeted and killed cancer cells but didn't overcome drug resistance.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Nilotinib can cause generalized keratosis pilaris.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Certain cancer drugs can cause skin issues like rashes and itching.